P. H. Lee and K. Lee
4-{3-[1-(tert-Butyldimethylsilanyloxy)ethyl]-4-oxoazetidin-2-yl}cyclohex-
4-ene-1,1,2,2-tetracarbonitrile (7 f): In a V-vial, a reaction mixture of 4
lar procedure to that described for 7g. M.p. 1898C; Rf =0.2 (EtOAc/
hexane 1:3); H NMR (400 MHz, CDCl3, 258C, TMS): isomer A: d=7.85
1
(s, 1H), 5.95–5.91 (m, 1H), 5.80 (s, 1H), 4.25–4.17 (m, 2H), 3.21–3.15 (m,
2H), 2.70–2.65 (m, 2H), 1.14 (d, J=6.24 Hz, 3H), 0.87 (s, 9H), 0.08 ppm
(s, 6H); isomer B d=7.97 (s, 1H), 5.95–5.91 (m, 1H), 5.84 (s, 1H), 4.25–
4.17 (m, 2H), 3.27–3.20 (m, 2H), 2.77–2.72 (m, 2H), 1.23 (d, J=6.21Hz,
3H), 0.87 (s, 9H), 0.08 ppm (s, 6H); (100 MHz, CDCl3, 258C, TMS): iso-
mer A: d=179.3, 179.0, 168.4, 138.9, 123.4, 65.0, 63.8, 53.4, 40.7, 40.3,
25.7, 24.0, 23.3, 22.7, 17.9, À4.2, À4.9 ppm; isomer B: d=179.3, 179.0,
168.3, 139.2, 122.7, 65.0, 64.5, 52.9, 40.39, 40.32, 25.7, 24.0, 23.3, 22.6, 17.9,
(140.7 mg, 0.5 mmol) and tetra(cyano)ethylene (128.1 mg, 1.0 mmol) in
G
benzene (0.8 mL) was refluxed at 838C. After this mixture had been
stirred for 5 h, it was poured into saturated ammonium chloride solution
(10 mL), extracted with CH2Cl2 (3ꢁ20 mL), and washed with brine
(20 mL). The organic layer was dried over anhydrous MgSO4 and evapo-
rated under reduced pressure. The crude product was purified by silica
gel column chromatography (EtOAc/hexane 1:1) to afford 7 f (175.6 mg,
86%). M.p. 1768C; Rf =0.6 (EtOAc/hexane 1:1); 1H NMR (400 MHz,
[D6]DMSO, 258C, TMS): d=8.23 (s, 1H), 5.83 (s, 1H), 4.08 (t, J=
5.41Hz, 1H), 4.00 (s, 1H), 3.51 (s, 1H), 3.45 (s, 1H), 3.34 (d, J=
10.22 Hz, 1H), 3.14 (d, J=18.65 Hz, 1H), 2.83 (dd, J=2.31, 2.31 Hz,
1H), 1.10 (d, J=6.22 Hz, 3H), 0.79 (s, 9H), 0.01ppm (s, 6H); 13C NMR
(100 MHz, [D6]DMSO, 258C, TMS): d=167.1, 132.6, 116.3, 111.7, 111.6,
111.4, 64.9, 64.0, 51.7, 30.7, 30.2, 25.8, 22.2, 17.7, À4.2, À4.8 ppm; IR
À4.2, À4.9 ppm; IR (KBr): n˜ =3241, 2954, 1714, 1161, 778 cmÀ1
.
5-{3-[1-(tert-Butyldimethylsilanyloxy)ethyl]-4-oxoazetidin-2-yl}-2-propyl-
3a,4,7,7a-tetrahydroisoindole-1,3-dione (7k) : In a V-vial, a reaction mix-
ture of 4 (56.3 mg, 0.2 mmol), N-ethylmaleimide (50.0 mg, 0.4 mmol), and
indium trichloride (1.9 mg, 0.01 mmol) in acetonitrile (0.3 mL) was
stirred at 258C. After the reaction mixture had been stirred for 24 h, it
was poured into saturated ammonium chloride solution (10 mL), extract-
ed with CH2Cl2 (3ꢁ20 mL), and washed with brine (20 mL). The organic
layer was dried over anhydrous MgSO4 and evaporated under reduced
pressure. The crude product was purified by silica gel column chromatog-
raphy (EtOAc/hexane 1:3) to afford 7k (75.6 mg, 93%). M.p. 1548C;
Rf =0.4 (EtOAc/hexane 1:3); 1H NMR (400 MHz, CDCl3, 258C, TMS):
d=5.88 (d, J=12.03 Hz, 2H), 4.24–4.15 (m, 1H), 4.11 (s, 1H), 3.49 (dd,
J=7.16, 7.05 Hz, 2H), 3.16–3.07 (m, 3H), 2.24–2.08 (m, 2H), 1.25 (d, J=
6.30, 3H), 1.09 (t, J=3.78, 7.16 Hz, 3H), 0.87 (s, 9H), 0.08 ppm (d, J=
3.84 Hz, 6H); 13C NMR (100 MHz, CDCl3, 258C, TMS): d=179.5, 179.3,
168.2, 139.1, 122.2, 65.0, 64.7, 52.8, 39.4, 39.0, 33.9, 25.7, 24.2, 23.1, 22.6,
(KBr): n˜ =3433, 1686, 707 cmÀ1
.
4-{3-[1-(tert-Butyldimethylsilanyloxy)ethyl]-4-oxoazetidin-2-yl}cyclohexa-
1,4-diene-1,2-dicarboxylic acid dimethyl ester (7g): In a V-vial, a reaction
mixture of 4 (140.7 mg, 0.5 mmol) and dimethylacetylene dicarboxylate
(98.1mg, 1.0 mmol) in benzene (0.8 mL) was refluxed at 83 8C. After the
mixture had been stirred for 48 h, it was poured into saturated ammoni-
um chloride solution (10 mL), extracted with CH2Cl2 (3ꢁ20 mL), and
washed with brine (20 mL). The organic layer was dried over anhydrous
MgSO4 and evaporated under reduced pressure. The crude product was
purified by silica gel column chromatography (EtOAc/hexane 1:3) to
afford 7g (175.7 mg, 83%). M.p. 1998C; Rf =0.1(EtOAc/hexane 1:)1;
1H NMR (400 MHz, CDCl3, 258C, TMS): d=6.00 (s, 1H), 5.76 (s, 1H),
4.20 (t, J=5.78 Hz, 1H), 4.13 (s, 1H), 3.79 (s, 6H), 3.09–3.05 (m, 3H),
2.99–2.94 (m, 1H), 2.89 (dd, J=2.13, 1.98 Hz, 1H), 1.24 (d, J=6.27 Hz,
3H), 0.88 (s, 9H), 0.09 ppm (s, 1H); 13C NMR (100 MHz, CDCl3, 258C,
TMS): d=168.3, 168.2, 167.9, 132.8, 132.5, 131.5, 118.0, 65.5, 64.7, 53.9,
52.3, 52.4, 28.3, 27.2, 25.7, 22.7, 17.9, À4.2, À4.7 ppm; IR (KBr): n˜ =3310,
17.9, 13.2, À4.2, À4.9 ppm; IR (KBr): n˜ =3235, 2950, 1754, 778 cmÀ1
.
5-{3-[1-(tert-Butyldimethylsilanyloxy)ethyl]-4-oxoazetidin-2-yl}-2-phenyl-
3a,4,7,7a-tetrahydroisoindole-1,3-dione (7l) : Compound 7l was prepared
by a similar procedure to that described for 7k. M.p. 1938C; Rf =0.7
(EtOAc); 1H NMR (400 MHz, CDCl3, 258C, TMS): d=7.47 (t, J=
7.62 Hz, 2H), 7.39 (t, J=7.12 Hz, 1H), 7.19 (d, J=7.73 Hz, 2H), 5.97 (t,
J=3.24 Hz, 1H), 5.58 (s, 1H), 4.21 (t, J=8.06 Hz, 2H), 3.38–3.27 (m,
2H), 2.87–2.75 (m, 3H), 2.38–2.25 (m, 2H), 1.24 (d, J=3.12 Hz), 0.88 (s,
9H), 0.73 ppm (s, 6H); 13C NMR (100 MHz, CDCl3, 258C, TMS): d=
178.8, 178.6, 168.1, 139.4, 131.1, 129.2, 128.7, 126.2, 122.4, 65.0, 64.7, 52.8,
39.6, 39.1, 25.7, 24.5, 23.2, 22.6, 17.9, À4.2, À4.9 ppm; IR (KBr): n˜ =3280,
2953, 1729, 1263, 1263 cmÀ1
.
4-{3-[1-(tert-Butyldimethylsilanyloxy)ethyl]-4-oxoazetidin-2-yl}cyclohex-
4-ene-1,2-dicarboxylic acid dimethyl ester (7h): Compound 7h was pre-
pared by a similar procedure to that described for 7g by using 6c
(4 equiv). M.p. 928C; Rf =0.1(EtOAc/hexane 1:3); 1H NMR (400 MHz,
CDCl3, 258C, TMS): isomer A: d=6.07 (s, 1H), 5.73 (d, J=5.16 Hz, 1H),
4.21–4.15 (m, 1H), 3.70 (s, 6H), 2.91–2.84 (m, 2H), 2.49 (t, J=16.46 Hz,
2H), 2.26–2.17 (m, 2H), 1.23 (dd, J=6.24, 6.09 Hz, 3H), 0.88 (s, 9H),
0.08 ppm (s, 6H); isomer B: d=6.10 (s, 2H), 5.73 (d, J=5.16 Hz, 1H),
4.21–4.15 (m, 1H), 3.70 (s, 6H), 2.91–2.84 (m, 2H), 2.49 (t, J=16.46 Hz,
2H), 2.26–2.17 (m, 2H), 1.23 (dd, J=6.24, 6.09 Hz, 3H), 0.88 (s, 9H),
0.08 ppm (s, 6H); 13C NMR (100 MHz, CDCl3, 258C, TMS): isomer A:
d=174.3, 174.1, 168.29, 134.1, 120.0, 65.3, 63.8, 53.8, 53.7, 51.4, 40.56,
40.48, 26.8, 25.1, 22.0, 17.3, 13.5, À5.3, À5.4 ppm; isomer B: d=174.3,
174.2, 168.2, 134.2, 119.5, 64.9, 64.5, 53.8, 53.7, 51.4, 49.4, 40.41, 26.9, 25.1,
22.1, 20.4, 17.3, 13.5, À4.8, À5.3 ppm; IR (KBr): n˜ =3324, 2953, 2249,
2953, 1760, 1444, 777 cmÀ1
.
3-[1-(tert-Butyldimethylsilanyloxy)ethyl]-4-(9,10-dihydroxy-1,4-dihydro-
anthracen-2-yl)azetidin-2-one (7m): Compound 7m was prepared by a
AHCTREUNG
similar procedure to that described for 7g. M.p. 1928C; Rf =0.6 (EtOAc/
hexane 1:1); 1H NMR (400 MHz, CDCl3, 258C, TMS): d=8.12–8.09 (m,
2H), 7.74–7.71(m, 2H), 5.93 (s, 1H), 5.86 (s, 1H), 4.27 (d,
J=5.65 Hz,
2H), 3.32–3.29 (m, 2H), 3.26–3.23 (m, 2H), 2.97 (s, 1H), 1.28 (d, J=
6.13 Hz, 3H), 0.91 (s, 9H), 0.12 ppm (d, J=4.67 Hz, 6H); 13C NMR
(100 MHz, CDCl3, 258C, TMS): d=166.9, 133.1, 115.8, 110.3, 110.2,
110.1, 110.0, 66.2, 65.5, 53.0, 37.6, 37.4, 32.5, 32.4, 25.7, 17.9, À4.2,
À4.6 ppm; IR (KBr): n˜ =3184, 2926, 1755, 1669, 730 cmÀ1
.
1653, 731 cmÀ1
.
4-{3-[1-(tert-Butyldimethylsilanyloxy)ethyl]-4-oxoazetidin-2-yl}cyclohex-
4-ene-1,2-dicarboxylic acid dimethyl ester (7i): Compound 7i was pre-
pared by a similar procedure to that described for 7g by using 6 f
Acknowledgements
(4 equiv). Rf =0.1(EtOAc/hexane :13);
1H NMR (400 MHz, CDCl3,
258C, TMS): isomer A: d=5.96 (s, 1H), 5.71 (s, 1H), 4.22–4.19 (m, 1H),
4.11 (d, J=6.03 Hz, 1H), 3.69 (t, J=4.17 Hz, 6H), 3.08 (m, 2H), 2.87 (d,
J=2.97, 1H), 2.58 (m, 2H), 2.34 (m, 2H), 1.25 (m, 3H), 0.88 (s, 9H),
0.08 ppm (s, 6H); isomer B d=5.96 (s, 1H), 5.71 (s, 1H), 4.22–4.19 (m,
1H), 4.11 (d, J=6.03 Hz, 1H), 3.69 (t, J=4.17 Hz, 6H), 3.08 (m, 2H),
2.84 (d, J=2.61, 1H), 2.58 (m, 2H), 2.34 (m, 2H), 1.25 (m, 3H), 0.88 (s,
9H), 0.08 ppm (s, 6H); 13C NMR (100 MHz, CDCl3, 258C, TMS): iso-
mer A: d=173.4, 173.1, 168.6, 134.8, 120.7, 65.5, 64.7, 54.3, 52.0, 39.9,
39.6, 25.7, 25.3, 22.6, 17.9, 14.2, À4.23, À4.84 ppm; isomer B: d=173.2,
173.1, 168.6, 134.9, 120.9, 65.4, 64.6, 54.2, 51.9, 39.7, 34.6, 25.6, 25.4, 22.7,
17.9, 14.2, À4.27, À4.88 ppm; IR (film): n˜ =3324, 2953, 2249, 1653,
This work was supported by the Korea Science and Engineering Founda-
tion (KOSEF, R01–2006–000–11283–0), by the KOSEF through the Na-
tional Research Lab. Program funded by the Ministry of Science and
Technology (grant no. M10600000203–06 J0000–20310), and by the
CMDS at KAIST. The NMR and mass data were obtained from the cen-
tral instrumental facility in Kangwon National University. We thank Pro-
fessor Y. Kang for assistance with X-ray crystallography.
[1] A. J. Wright, Mayo Clin. Proc. 1999, 74, 290–307.
[2] a) M. S. Manhas, D. R. Wagle, J. Chiang, A. K. Bose, Heterocycles
1988, 27, 1755; b) G. I. Georg, The Organic Chemistry of b-Lactams;
Wiley-VCH, New York, 1992; c) I. Ojima, Adv. Asymmetric Synth.
731cm À1
.
5-{3-[1-(tert-Butyldimethylsilanyloxy)ethyl]-4-oxoazetidin-2-yl}-3a,4,7,7a-
tetrahydroisoindole-1,3-dione (7j): Compound 7j was prepared by a simi-
8882
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2007, 13, 8877 – 8883